Globus Medical (GMED) Tops Q2 EPS by 18c

Go back to Globus Medical (GMED) Tops Q2 EPS by 18c

Globus Medical Reports Second Quarter 2020 Results

August 5, 2020 4:16 PM EDT

AUDUBON, Pa., Aug. 05, 2020 (GLOBE NEWSWIRE) -- Globus Medical, Inc. (NYSE: GMED), a leading musculoskeletal solutions company, today announced its financial results for the second quarter ended June 30, 2020.

Worldwide sales were $148.9 million, a decrease of 23.4% as reported Second quarter net loss was $20.8 million Diluted earnings per share (EPS) was $(0.21) and non-GAAP diluted EPS was $0.07 Non-GAAP adjusted EBITDA was 14.7% of... More